Skip to content
Screener

Oscar Health OSCR Q4 2025 Annual earnings

Reported February 10, 2026 · Before market open

Revenue$2.7BMiss by $376.7M
EPS-$1.24Miss by $0.32
Revenue estimate$3.1B
EPS estimate-$0.92

Next report

Nov 9, 2026 (In 4 weeks)
Revenue estimate$4.7B
EPS estimate-$0.14

Financials

Q4 2025

Income statement

See full
Revenue$2.8B+17.3%
Operating income-$333.7M—
Net income-$352.6M—
EPS (diluted)-$1.34—

Balance sheet

See full
Cash & equivalents$2.8B+80.8%
Total debt$498.8M+33.5%
Total equity$977.6M-3.5%
Total assets$6.3B+30.7%

Cash flow

See full
Operating cash flow$671.9M+93.7%
CapEx$9.1M+32.9%
Free cash flow$662.8M+95.0%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$4.14B+24.5%
Enterprise value$1.83B-14.6%
P/S0.4×0.0×

Profitability

See full
Operating margin-3.4%—
Net margin-3.8%—

Returns & leverage

See full
Return on equity-44.5%—
Debt / equity0.5×+0.1×
Current ratio0.9×+0.1×

FAQ

When did Oscar Health report Q4 2025 earnings?
Oscar Health (OSCR) reported Q4 2025 earnings on February 10, 2026 before market open.
What were Oscar Health's Q4 2025 revenue and EPS?
Oscar Health reported revenue of $2.7B and eps of $-1.24 for Q4 2025.
Did Oscar Health beat estimates in Q4 2025?
Revenue missed the consensus estimate of $3.1B by $376.7M. EPS missed the consensus estimate of $-0.92 by $0.32.
How did Oscar Health's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 14.8% from $2.4B a year earlier and eps declined 100.0% from $-0.62.
Where can I find Oscar Health's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001568651-26-000008) and the 10-K periodic report (0001568651-26-000011) directly on SEC EDGAR. The filing index links above go to sec.gov.